SCHEMBL13672178

SCHEMBL13672178

C/C=C1/CC2CC(C)(C1)CN2C(=O)c1ccc(N2N=C(C)CC2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
KMT2A Q03164 6/20 0.42
MEN1 O00255 5/20 0.42
TDP1 Q9NUW8 5/20 0.42
MAPT P10636 5/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 3/20 0.39
KDM4E B2RXH2 5/20 0.39
RECQL P46063 1/20 0.39
SMYD3 Q9H7B4 2/20 0.39
GAA P10253 3/20 0.39
CYP1A2 P05177 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP3A4 P08684 1/20 0.39
CHRM1 P11229 1/20 0.39
TSHR P16473 1/20 0.39
PTGS1 P23219 1/20 0.39
DRD3 P35462 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672183 0.82 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1TDP1HTT
SCHEMBL3455020 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1TDP1HTT
SCHEMBL13672184 0.79 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1TDP1HTT
SCHEMBL13672414 0.79 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL13672181 0.78 NPSR1 (0.46) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL13672416 0.78 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL13672523 0.78 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL13672173 0.77 PREP (0.45) ALDH1A1KMT2AMEN1TDP1HTT
SCHEMBL13672177 0.77 DPP4 (0.41) ALDH1A1KMT2AMEN1TDP1MAPT
SCHEMBL13672415 0.77 CYP3A4 (0.44) ALDH1A1KMT2AMEN1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264414-A1 Amide Derivatives and Pharmaceutical Use Thereof HIGH POINT PHARMACEUTICALS, LLC (US) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264414-A1 Amide Derivatives and Pharmaceutical Use Thereof HSD11B1, HSD11B2, HSD3B1 ALDH1A1 232/4885KMT2A 2931/4885MEN1 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.